UnitedHealth Group Incorporated (NYSE:UNH) Shares Acquired by Key Financial Inc

Key Financial Inc raised its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 3,892 shares of the healthcare conglomerate’s stock after purchasing an additional 84 shares during the period. Key Financial Inc’s holdings in UnitedHealth Group were worth $1,969,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of UNH. AlphaMark Advisors LLC acquired a new stake in shares of UnitedHealth Group in the 4th quarter worth approximately $30,000. RPg Family Wealth Advisory LLC acquired a new position in UnitedHealth Group during the third quarter valued at $37,000. DecisionPoint Financial LLC boosted its holdings in shares of UnitedHealth Group by 155.0% during the fourth quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock worth $52,000 after purchasing an additional 62 shares during the period. Highline Wealth Partners LLC purchased a new stake in UnitedHealth Group in the 3rd quarter worth approximately $55,000. Finally, Legacy Investment Solutions LLC acquired a new stake in UnitedHealth Group during the third quarter valued at $57,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on UNH shares. Wells Fargo & Company decreased their price target on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. Piper Sandler dropped their price objective on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a report on Thursday, January 2nd. Hsbc Global Res raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. Finally, Stephens lifted their target price on shares of UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research report on Thursday, December 5th. One equities research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Buy” and an average target price of $629.32.

UnitedHealth Group Trading Down 1.4 %

Shares of UNH opened at $523.48 on Tuesday. The stock has a market capitalization of $481.75 billion, a P/E ratio of 33.77, a PEG ratio of 1.45 and a beta of 0.61. The firm has a fifty day simple moving average of $523.11 and a two-hundred day simple moving average of $563.00. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. During the same quarter in the previous year, the business posted $5.83 EPS. UnitedHealth Group’s revenue was up 6.8% compared to the same quarter last year. On average, research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

Insider Activity at UnitedHealth Group

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the firm’s stock in a transaction on Friday, January 17th. The stock was acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the purchase, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 0.33% of the stock is owned by company insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.